Synchronized cycles of bacterial lysis for in vivo delivery
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The widespread view of bacteria as strictly pathogenic has given way to an appreciation of the prevalence of some beneficial microbes within the human body. It is perhaps inevitable that some bacteria would evolve to preferentially grow in environments that harbor disease and thus provide a natural platform for the development of engineered therapies. Such therapies could benefit from bacteria that are programmed to limit bacterial growth while continually producing and releasing cytotoxic agents in situ. Here we engineer a clinically relevant bacterium to lyse synchronously ata threshold population density and to release genetically encoded cargo. Following quorum lysis, a small number of surviving bacteria reseed the growing population, thus leading to pulsatile delivery cycles. We used microfluidic devices to characterize the engineered lysis strain and we demonstrate its potential as a drug delivery platform via co-culture with human cancer cells in vitro. Asa proof of principle, we tracked the bacterial population dynamics in ectopic syngeneic colorectal tumours in mice via a luminescent reporter. The lysis strain exhibits pulsatile population dynamics in vivo, with mean bacterial luminescence that remained two orders of magnitude lower than an unmodified strain. Finally, guided by previous findings that certain bacteria can enhance the efficacy of standard therapies, we orally administered the lysis strain alone or in combination with a clinical chemotherapeutic to a syngeneic mouse transplantation model of hepatic colorectal metastases. We found that the combination of both circuit-engineered bacteria and chemotherapy leads to a notable reduction of tumour activity along with a marked survival benefit over either therapy alone.Our approach establishes a methodology for leveraging the tools of synthetic biology to exploit the natural propensity for certain bacteria to colonize disease sites.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An interesting general approach implements engineered bacterial lysis, which enables antitumor protein production or release only when a predefined population density of bacteria is reached (154–157).”
From The microbiome and human cancer (2021) · cites this paper as [155]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The human microbiome: at the interface of health and disease
Cho, I., & Blaser, M. J. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3182 · Cited by 3,449
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
Davila, M. L., Riviere, I., Wang, X., Bartido, S., Park, J., Curran, K., Chung, S. S., Stefanski, J., Borquez-Ojeda, O., Olszewska, M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008226 · Cited by 2,476
Garrett, W. S. (2015) · Science · doi:10.1126/science.aaa4972 · Cited by 1,404
A synchronized quorum of genetic clocks
Danino, T., Mondragón-Palomino, O., Tsimring, L., & Hasty, J. (2010) · Nature · doi:10.1038/nature08753 · Cited by 992
Self-citationLeone, V., Gibbons, S. M., Martinez, K., Hutchison, A. L., Huang, E. Y., Cham, C. M., Pierre, J. F., Heneghan, A. F., Nadimpalli, A., Hubert, N., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.03.006 · Cited by 911
Engineering the perfect (bacterial) cancer therapy
Forbes, N. S. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2934 · Cited by 905 · cited 1×
“Thus a synergistic effect may arise when bacteria are used to deliver drugs to the necrotic core of a tumor, while standard chemotherapy is used for the vascularized regions 11,26 .”
BackgroundCombination bacteriolytic therapy for the treatment of experimental tumors
Dang, L. H., Bettegowda, C., Huso, D. L., Kinzler, K. W., & Vogelstein, B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251543698 · Cited by 563
Microbial Dysbiosis Is Associated with Human Breast Cancer
Xuan, C., Shamonki, J. M., Chung, A., DiNome, M. L., Chung, M., Sieling, P. A., & Lee, D. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0083744 · Cited by 543
Tumor-targeted Salmonella as a novel anticancer vector.
Pawelek, J. M., Low, K. B., & Bermudes, D. G. (1997) · PubMed · Cited by 527
Programmable probiotics for detection of cancer in urine
Danino, T., Prindle, A., Kwong, G. A., Skalak, M., Li, H., Allen, K., Hasty, J., & Bhatia, S. N. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa3519 · Cited by 467
Self-citation
Cited by
Items 201–300 of 782
Hydrogels as promising platforms for engineered living bacteria-mediated therapeutic systems
Yu, S., Sun, H., Li, Y., Wei, S., Xu, J., & Liu, J. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100435 · Cited by 60
A red light-controlled probiotic bio-system for in-situ gut-brain axis regulation
Zhang, X., Pang, G., Sun, T., Liu, X., Pan, H., Zhang, Y., Liu, J., Chang, J. K., Wang, H., & Liu, D. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122005 · Cited by 49
MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation
Zheng, Y., Wei, Z., & Wang, T. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1120533 · Cited by 58
Cancer phototherapy with nano-bacteria biohybrids
Lu, H., Niu, L., Yu, L., Jin, K., Zhang, J., Liu, J., Zhu, X., Wu, Y., & Zhang, Y. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.06.009 · Cited by 46
Challenges and opportunities in delivering oral peptides and proteins
Peng, H., Wang, J., Chen, J., Peng, Y., Wang, X., Chen, Y., Kaplan, D. L., & Wang, Q. (2023) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2023.2237408 · Cited by 57
In situ immunomodulation of tumors with biosynthetic bacteria promote anti-tumor immunity
Lin, Z., Meng, F., Ma, Y., Zhang, C., Zhang, Z., Yang, Z., Li, Y., Hou, L., Xu, Y., Liang, X., et al. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.09.007 · Cited by 66
Optoregulated Protein Release from an Engineered Living Material
Sankaran, S., & del Campo, A. (2018) · Advanced Biosystems · doi:10.1002/adbi.201800312 · Cited by 47
Meisami, A. H., Abbasi, M., Mosleh-Shirazi, S., Azari, A., Amani, A. M., Vaez, A., & Golchin, A. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175011 · Cited by 47
Overcoming the challenges of cancer drug resistance through bacterial‐mediated therapy
Zargar, A., Chang, S., Kothari, A., Snijders, A. M., Mao, J., Wang, J. C., Hernández, A. C., Keasling, J. D., & Bivona, T. G. (2019) · Chronic Diseases and Translational Medicine · doi:10.1016/j.cdtm.2019.11.001 · Cited by 58
Reghu, S., & Miyako, E. (2022) · Nano Letters · doi:10.1021/acs.nanolett.1c04037 · Cited by 48
Mi, Z., Chen, J., Zhang, Z., Liu, J., Lei, Y., Tan, H., Li, W., Chen, X. S., & Rong, P. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.ado8395 · Cited by 53
Nanotechnology-Employed Bacteria-Based Delivery Strategy for Enhanced Anticancer Therapy
Ye, Z., Liang, L., Lu, H., Shen, Y., Zhou, W., & Li, Y. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s329855 · Cited by 50
Microfluidics for long-term single-cell time-lapse microscopy: Advances and applications
Allard, P., Papazotos, F., & Potvin-Trottier, L. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.968342 · Cited by 52
Programming Cells to Work for Us
Qian, Y., McBride, C. D., & Vecchio, D. D. (2017) · Annual Review of Control Robotics and Autonomous Systems · doi:10.1146/annurev-control-060117-105052 · Cited by 48
Singh, A. K., Brito, I., & Lammerding, J. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.01.008 · Cited by 49
Jeong, Y., & Irudayaraj, J. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.01.003 · Cited by 44
Systems and synthetic biology-driven engineering of live bacterial therapeutics
Kim, K., Kang, M., & Cho, B. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1267378 · Cited by 55
Cancer Immunotherapy: Priming the Host Immune Response with Live Attenuated Salmonella enterica
Hernández-Luna, M. A., & Luría-Pérez, R. (2018) · Journal of Immunology Research · doi:10.1155/2018/2984247 · Cited by 53
Divergent metabolic programmes control two populations of MAIT cells that protect the lung
Riffelmacher, T., Murray, M. P., Wientjens, C., Chandra, S., Castelan, V. O. C., Chou, T.-F., McArdle, S., Dillingham, C. H., Devereaux, J., Nilsen, A., et al. (2023) · Nature Cell Biology · doi:10.1038/s41556-023-01152-6 · Cited by 43
Self-citationBascuas, T., Moreno, M., Grille, S., & Chabalgoity, J. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00007 · Cited by 47
Rapid screening of engineered microbial therapies in a 3D multicellular model
Harimoto, T., Singer, Z. S., Velazquez, O. S., Zhang, J. T., Castro, S., Hinchliffe, T. E., Mather, W., & Danino, T. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1820824116 · Cited by 44
Self-citationControlled release of immunotherapeutics for enhanced cancer immunotherapy after local delivery
Jin, Q., Liu, Z., & Chen, Q. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.10.019 · Cited by 45
The promise and challenge of cancer microbiome research
Manzoor, S. S., Doedens, A. M., & Burns, M. B. (2020) · Genome biology · doi:10.1186/s13059-020-02037-9 · Cited by 43
Active microfluidic transport in two-dimensional handlebodies
Hardouïn, J., Laurent, J., López‐León, T., Ignés‐Mullol, J., & Sagués, F. (2020) · Soft Matter · doi:10.1039/d0sm00610f · Cited by 42
Reprogramming Synthetic Cells for Targeted Cancer Therapy
Lim, B., Yin, Y., Ye, H., Cui, Z., Papachristodoulou, A., & Huang, W. E. (2022) · ACS Synthetic Biology · doi:10.1021/acssynbio.1c00631 · Cited by 43
Gut microbiota and its therapeutic implications in tumor microenvironment interactions
Feng, P., Xue, X., Bukhari, I., Qiu, C., Li, Y., Zheng, P., & Mi, Y. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1287077 · Cited by 43
Plasmodium parasite as an effective hepatocellular carcinoma antigen glypican-3 delivery vector
Liu, Q., Yang, Y., Tan, X., Tao, Z., Adah, D., Yu, S., Lu, J., Zhao, S., Qin, L., Qin, L., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15806 · Cited by 42
Interfacing gene circuits with microelectronics through engineered population dynamics
Din, M. O., Martín, A., Razinkov, I., Csicsery, N., & Hasty, J. (2020) · Science Advances · doi:10.1126/sciadv.aaz8344 · Cited by 39
Self-citationEngineered Bacteria for Disease Diagnosis and Treatment Using Synthetic Biology
Jin, K., Huang, Y. B., Che, H., & Wu, Y. (2025) · Microbial Biotechnology · doi:10.1111/1751-7915.70080 · Cited by 59
Modulating tumor immunity using advanced microbiome therapeutics producing an indole metabolite
Vaaben, T. H., Lützhøft, D. O., Koulouktsis, A., Dawoodi, I. M., Stavnsbjerg, C., Kvich, L., Gögenür, I., Vazquez-Uribe, R., & Sommer, M. O. A. (2025) · EMBO Reports · doi:10.1038/s44319-025-00386-9 · Cited by 41
Systems and synthetic biology approaches in understanding biological oscillators
Li, Z., & Yang, Q. (2018) · Quantitative Biology · doi:10.1007/s40484-017-0120-7 · Cited by 43
Immunoreceptor Engineering and Synthetic Cytokine Signaling for Therapeutics
Scheller, J., Engelowski, E., Moll, J. M., & Floss, D. M. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.01.001 · Cited by 39
A rapid screening platform to coculture bacteria within tumor spheroids
Harimoto, T., Deb, D., & Danino, T. (2022) · Nature Protocols · doi:10.1038/s41596-022-00723-5 · Cited by 43
Self-citationRecent advances in plasmid-based tools for establishing novel microbial chassis
Nora, L. C., Westmann, C. A., Guazzaroni, M., Siddaiah, C. N., Gupta, V. K., & Silva‐Rocha, R. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.107433 · Cited by 42
Programming living sensors for environment, health and biomanufacturing
Wan, X., Saltepe, B., Yu, L., & Wang, B. (2021) · Microbial Biotechnology · doi:10.1111/1751-7915.13820 · Cited by 39
Bioengineered Biomimetic and Bioinspired Noninvasive Drug Delivery Systems
Rahamim, V., & Azagury, A. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202102033 · Cited by 41
Current Status and Future Directions of Bacteria-Based Immunotherapy
Tang, Q., Peng, X., Xu, B., Zhou, X., Chen, J., & Cheng, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.911783 · Cited by 41
Raman, V., Deshpande, C. P., Khanduja, S., Howell, L. M., Dessel, N. V., & Forbes, N. S. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.09.006 · Cited by 38
Biomimetic oral targeted delivery of bindarit for immunotherapy of atherosclerosis
Yin, L., Peng, C., Tang, Y., Yuan, Y., Liu, J., Xiang, T., Liu, F., Zhou, X. W., & Li, X. (2020) · Biomaterials Science · doi:10.1039/d0bm00418a · Cited by 39
Optically activatable photosynthetic bacteria-based highly tumor specific immunotheranostics
Yang, X., Komatsu, S., Reghu, S., & Miyako, E. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101100 · Cited by 39
Galhano, J., Marcelo, G. A., Duarte, M. P., & Oliveira, E. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105470 · Cited by 38
Engineered bacteria for augmented in situ tumor vaccination
Shen, X., Zhu, C., Liu, X., Zheng, H., Wu, Q., Xie, J., Huang, H., Liao, Z., Shi, J., Nan, K., et al. (2023) · Biomaterials Science · doi:10.1039/d2bm01593e · Cited by 38
Design of nanorobots for exposing cancer cells
Dolev, S., Narayanan, R. P., & Rosenblit, M. (2019) · Nanotechnology · doi:10.1088/1361-6528/ab1770 · Cited by 40
Engineering microbial diagnostics and therapeutics with smart control
Amrofell, M. B., Rottinghaus, A. G., & Moon, T. S. (2020) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2020.05.006 · Cited by 35
Design of synthetic bacterial biosensors
Chiang, A. J., & Hasty, J. (2023) · Current Opinion in Microbiology · doi:10.1016/j.mib.2023.102380 · Cited by 37
Self-citationAvilés‐Jiménez, F., Yu, G., Torres-Poveda, K., Madrid‐Marina, V., & Torres, J. (2017) · Archives of Medical Research · doi:10.1016/j.arcmed.2017.11.008 · Cited by 36
Self-assembly of active amphiphilic Janus particles
Mallory, S. A., Alarcón, F., Cacciuto, A., & Valeriani, C. (2017) · New Journal of Physics · doi:10.1088/1367-2630/aa9b77 · Cited by 34
An RGB-emitting molecular cocktail for the detection of bacterial fingerprints
Hong, S., Zheng, D., Zhang, Q., Deng, W., Song, W., Cheng, S., Sun, Z., & Zhang, X. (2020) · Chemical Science · doi:10.1039/d0sc01704c · Cited by 34
Integration of Salmonella into Combination Cancer Therapy
Al-Saafeen, B. H., Fernández-Cabezudo, M. J., & al-Ramadi, B. K. (2021) · Cancers · doi:10.3390/cancers13133228 · Cited by 40
Strategies for Improving Small-Molecule Biosensors in Bacteria
Miller, C. A., Ho, J. M. L., & Bennett, M. R. (2022) · Biosensors · doi:10.3390/bios12020064 · Cited by 37
Sepich‐Poore, G. D., Guccione, C., Laplane, L., Pradeu, T., Curtius, K., & Knight, R. (2022) · BioEssays · doi:10.1002/bies.202100252 · Cited by 33
Synthetic bacterial therapies for intestinal diseases based on quorum-sensing circuits
Dang, Z., Gao, M., Wang, L., Wu, J., Guo, Y., Zhu, Z., Huang, H., & Kang, G. (2023) · Biotechnology Advances · doi:10.1016/j.biotechadv.2023.108142 · Cited by 36
Advancing therapeutic applications of synthetic gene circuits
Higashikuni, Y., Chen, W. C. W., & Lu, T. K. (2017) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2017.06.011 · Cited by 36
Dynamic and tunable metabolite control for robust minimal-equipment assessment of serum zinc
McNerney, M. P., Michel, C. L., Kishore, K., Standeven, J., & Styczynski, M. P. (2019) · Nature Communications · doi:10.1038/s41467-019-13454-1 · Cited by 34
New technologies in developing recombinant‐attenuated bacteria for cancer therapy
Liang, K., Liu, Q., & Kong, Q. (2020) · Biotechnology and Bioengineering · doi:10.1002/bit.27596 · Cited by 35
Perrino, G., Hadjimitsis, A., Ledesma‐Amaro, R., & Stan, G.-B. V. (2021) · Current Opinion in Microbiology · doi:10.1016/j.mib.2021.05.004 · Cited by 36
Advances in the Microbiome: Applications to Clostridium difficile Infection
Culligan, E. P., & Sleator, R. D. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5090083 · Cited by 39
A Simply Modified Lymphocyte for Systematic Cancer Therapy
Zheng, D., Fan, J., Liu, X., Dong, X., Pan, P., Xu, L., & Zhang, X. (2018) · Advanced Materials · doi:10.1002/adma.201801622 · Cited by 32
Rational programming of history-dependent logic in cellular populations
Zúñiga, A., Guiziou, S., Mayonove, P., Meriem, Z. B., Rufino, M. C., Moreau, V., Ciandrini, L., Hersen, P., & Bonnet, J. (2020) · Nature Communications · doi:10.1038/s41467-020-18455-z · Cited by 30
Combinational quorum sensing devices for dynamic control in cross-feeding cocultivation
Wu, S., Xue, Y., Yang, S., Xu, C., Liu, C., Liu, X., Liu, J., Zhu, H., Zhao, G.-R., Yang, A., et al. (2021) · Metabolic Engineering · doi:10.1016/j.ymben.2021.07.002 · Cited by 30
Engineering temporal dynamics in microbial communities
Ronda, C., & Wang, H. H. (2021) · Current Opinion in Microbiology · doi:10.1016/j.mib.2021.10.009 · Cited by 36
Gao, Z., Zhang, E., Zhao, H., Xia, S., Bai, H., Huang, Y., Lv, F., Liu, L., & Wang, S. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c01493 · Cited by 32
Development of a TNF-α-mediated Trojan Horse for bacteria-based cancer therapy
Hu, C.-W., Chang, Y.-C., Liu, C.-H., Yu, Y., & Mou, Y. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.04.008 · Cited by 36
Decoding the microbiome: advances in genetic manipulation for gut bacteria
Chen, Z., Jin, W., Hoover, A., Chao, Y., & Ma, Y. (2023) · Trends in Microbiology · doi:10.1016/j.tim.2023.05.007 · Cited by 32
Advances in bacteria‐based drug delivery systems for anti‐tumor therapy
Han, S., Yifei, S., Wu, X., Zhanbo, Q., Xiang, Y., & Yang, X. (2024) · Clinical & Translational Immunology · doi:10.1002/cti2.1518 · Cited by 39
Current application and future prospects of CRISPR-Cas in lactic acid Bacteria: A review
Xin, Y., Guo, T., & Qiao, M. (2025) · Food Research International · doi:10.1016/j.foodres.2025.116315 · Cited by 35
Engineering bacteria for cancer therapy
Harimoto, T., & Danino, T. (2019) · Emerging Topics in Life Sciences · doi:10.1042/etls20190096 · Cited by 35
Self-citationEngineering E. coli for Magnetic Control and the Spatial Localization of Functions
Aubry, M., Wang, W., Guyodo, Y., Delacou, E., Guigner, J., Espéli, O., Lebreton, A., Guyot, F., & Gueroui, Z. (2020) · ACS Synthetic Biology · doi:10.1021/acssynbio.0c00286 · Cited by 35
Recent Update on Bacteria as a Delivery Carrier in Cancer Therapy: From Evil to Allies
Pandey, M., Choudhury, H., Vijayagomaran, P. A. P., Lian, P. N. P., Ning, T. J., Ng Zing, W. A. I., Xian-Zhuang, N., Er, C. L., Rahmah, N. S. N., Kamaruzzaman, N. D. B., et al. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03240-y · Cited by 32
Molecular Imaging in Synthetic Biology, and Synthetic Biology in Molecular Imaging
Gilad, A. A., & Shapiro, M. G. (2017) · Molecular Imaging and Biology · doi:10.1007/s11307-017-1062-1 · Cited by 30
Oral nanomedicine biointeractions in the gastrointestinal tract in health and disease
Chen, C., Beloqui, A., & Xu, Y. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115117 · Cited by 30
Multi-layered computational gene networks by engineered tristate logics
Shao, J., Qiu, X., Zhang, L., Li, S., Xue, S., Si, Y., Li, Y., Jiang, J., Wu, Y., Xiong, Q., et al. (2024) · Cell · doi:10.1016/j.cell.2024.07.001 · Cited by 35
Engineered bacteria: Strategies and applications in cancer immunotherapy
Zhang, S., Li, R., Xu, Y., Liu, R., Sun, D., & Dai, Z. (2024) · Fundamental Research · doi:10.1016/j.fmre.2024.11.001 · Cited by 35
Designing live bacterial therapeutics for cancer
Lee, J., McClure, S., Weichselbaum, R. R., & Mimee, M. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115579 · Cited by 35
Kim, S., Kerns, S. J., Ziesack, M., Bry, L., Gerber, G. K., Way, J. C., & Silver, P. A. (2018) · ACS Synthetic Biology · doi:10.1021/acssynbio.8b00271 · Cited by 34
Toward a translationally independent RNA-based synthetic oscillator using deactivated CRISPR-Cas
Kuo, J., Yuan, R., Sánchez, C. M., Paulsson, J., & Silver, P. A. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa557 · Cited by 31
Parker, M. T., & Kunjapur, A. M. (2020) · Health Security · doi:10.1089/hs.2020.0010 · Cited by 30
Microbial cell engineering to improve cellular synthetic capacity
Ding, Q., Diao, W., Gao, C., Chen, X., & Liu, L. (2020) · Biotechnology Advances · doi:10.1016/j.biotechadv.2020.107649 · Cited by 30
Engineering Living Bacteria for Cancer Therapy
Rong, L., Lei, Q., & Zhang, X. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c01286 · Cited by 32
Dong, J., Gao, H.-L., Wang, W., Yu, X., & Liu, L. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188484 · Cited by 31
Chen, X. J., Wang, B., Thompson, I. P., & Huang, W. E. (2021) · ACS Synthetic Biology · doi:10.1021/acssynbio.1c00223 · Cited by 34
Engineering Cyborg Bacteria Through Intracellular Hydrogelation
Contreras-Llano, L. E., Liu, Y., Henson, T., Meyer, C. C., Baghdasaryan, O., Khan, S. A., Lin, C., Wang, A., Hu, C. J., & Tan, C. (2023) · Advanced Science · doi:10.1002/advs.202204175 · Cited by 34
Vazquez-Uribe, R., Hedin, K. A., Licht, T. R., Nieuwdorp, M., & Sommer, M. O. A. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.04.021 · Cited by 28
Synthetic microbial ecology: engineering habitats for modular consortia
Chen, Y. C., Destouches, L., Cook, A., & Fedorec, A. J. H. (2024) · Journal of Applied Microbiology · doi:10.1093/jambio/lxae158 · Cited by 33
Synthetic biology approaches: Towards sustainable exploitation of marine bioactive molecules
Kiran, G. S., Ramasamy, P., Sekar, S., Meenatchi, R., Hassan, S., Ninawe, A. S., & Selvin, J. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.01.149 · Cited by 31
Development of Aspirin-Inducible Biosensors in Escherichia coli and SimCells
Chen, J. X., Steel, H., Wu, Y.-H., Wang, Y., Xu, J., Rampley, C. P. N., Thompson, I. P., Papachristodoulou, A., & Huang, W. E. (2019) · Applied and Environmental Microbiology · doi:10.1128/aem.02959-18 · Cited by 32
Novel Delivery Systems for Checkpoint Inhibitors
Lamichhane, P., Deshmukh, R. R., Brown, J. K., Jakubski, S., Parajuli, P., Nolan, T. A., Raja, D. S., Badawy, M., Yoon, T., Zmiyiwsky, M., et al. (2019) · Medicines · doi:10.3390/medicines6030074 · Cited by 32
Engineering self-organized criticality in living cells
Vidiella, B., Guillamon, A., Sardanyés, J., Maull, V., Pla, J., Pueyo, N. C., & Solé, R. V. (2021) · Nature Communications · doi:10.1038/s41467-021-24695-4 · Cited by 36
Perspectives on Oncolytic Salmonella in Cancer Immunotherapy—A Promising Strategy
Wang, D., Wei, X., Kalvakolanu, D. V., Guo, B., & Zhang, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.615930 · Cited by 32
Brevi, A., Cogrossi, L. L., Lorenzoni, M., Mattorre, B., & Bellone, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.845422 · Cited by 32
High efficiency hydrodynamic bacterial electrotransformation
Garcia, P. A., Ge, Z., Kelley, L. E., Holcomb, S. J., & Buie, C. (2017) · Lab on a Chip · doi:10.1039/c6lc01309k · Cited by 29
Review on Applied Applications of Microbiome on Human Lives
Kamble, N. S., Bera, S., Bhedase, S. A., Gaur, V., & Chowdhury, D. (2024) · Bacteria · doi:10.3390/bacteria3030010 · Cited by 33
Jin, X., Li, H., Pan, S., Song, B., Jiang, Y., Shi, H., Zhang, J., Chu, B., Wang, H., & He, Y. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c12139 · Cited by 30
Phototrophic purple bacteria as optoacoustic in vivo reporters of macrophage activity
Peters, L., Weidenfeld, I., Klemm, U., Loeschcke, A., Weihmann, R., Jaeger, K., Drepper, T., Ntziachristos, V., & Stiel, A. C. (2019) · Nature Communications · doi:10.1038/s41467-019-09081-5 · Cited by 31
Cui, W., Lin, Q., Hu, R., Han, L., Cheng, Z., Zhang, L., & Zhou, Z. (2021) · ACS Synthetic Biology · doi:10.1021/acssynbio.1c00050 · Cited by 29
Pierce, K. M., Miklavcic, W. R., Cook, K. P., Hennen, M. S., Bayles, K. W., Hollingsworth, M. A., Brooks, A. E., Pullan, J. E., & Dailey, K. M. (2021) · Nanomaterials · doi:10.3390/nano11113018 · Cited by 31
Genetically engineered control of phenotypic structure in microbial colonies
Bittihn, P., Didovyk, A., Tsimring, L. S., & Hasty, J. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0686-0 · Cited by 30
Self-citationAdvancement of Engineered Bacteria for Orally Delivered Therapeutics
Guo, P., Wang, S., Yue, H., Zhang, X., Ma, G., Li, X., & Wei, W. (2023) · Small · doi:10.1002/smll.202302702 · Cited by 30
Microbial quorum sensing: Mechanisms, applications, and challenges
Ruan, Q., Geng, S., Yu, J., Lu, L., Liu, Y., Chen, J., Liao, Q., & Guo, R. (2025) · Biotechnology Advances · doi:10.1016/j.biotechadv.2025.108733 · Cited by 37
Microbial cancer therapeutics: A promising approach
Diwan, D., Cheng, L., Usmani, Z., Sharma, M., Holden, N. J., Willoughby, N. A., Sangwan, N. S., Baadhe, R. R., Liu, C., & Gupta, V. K. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.05.003 · Cited by 28
Metadata
- Authors
- Din, M. O., Danino, T., Prindle, A., Skalak, M., Selimkhanov, J., Allen, K., Julio, E., Atolia, E., Tsimring, L. S., Bhatia, S. N., & Hasty, J.
- Affiliations
- University of California San Diego (US)
- Massachusetts Institute of Technology (US)
- Broad Institute (US)
- Corresponding author
- Hasty, Jeff
- ORCID
- Venue
- Nature
- Published
- 2016-07-20
- Volume
- 536
- Issue
- 7614
- Pages
- 81-85
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC5048415
- OpenAlex
- W2480697384
- Cited by
- 784
- References
- 31
- Citations by year
- 2026: 97 · 2025: 107 · 2024: 95 · 2023: 87 · 2022: 73 · 2021: 71 · 2020: 82 · 2019: 59 · 2018: 55 · 2017: 43 · 2016: 12
- FWCI
- 49.00
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
- PMC
- Funders
- Howard Hughes Medical Institute
- University of California, San Diego
- National Cancer Institute (K99CA197649, R00CA197649, DP1CA174420, P30CA014051)
- National Institute of General Medical Sciences (P50GM085764, R01GM069811)
- National Institute of Environmental Health Sciences (P30ES002109)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Keywords
- bacterial lysis, quorum sensing, synthetic biology, Salmonella, pulsatile drug delivery, cancer therapy, colorectal cancer, liver metastasis, bacterial population dynamics, luminescent reporter, combination chemotherapy, oral administration, living therapeutics
- MeSH terms
- Administration, Oral, Animals, Bacteriolysis, Computer Simulation, Female, Liver Neoplasms, Neoplasm Metastasis, Neoplasm Transplantation, Salmonella, Transplantation, Isogeneic, Colorectal Neoplasms, Drug Delivery Systems, Coculture Techniques, Luminescence, Mice, Quorum Sensing, Synthetic Biology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.